Teva Pharmaceutical Industries Total Current Liabilities 2010-2024 | TEVA

Teva Pharmaceutical Industries total current liabilities for the quarter ending September 30, 2024 were $13.797B, a 21.09% increase year-over-year.

  • Teva Pharmaceutical Industries total current liabilities for 2023 were $12.247B, a 6.78% increase from 2022.
  • Teva Pharmaceutical Industries total current liabilities for 2022 were $11.469B, a 4.01% increase from 2021.
  • Teva Pharmaceutical Industries total current liabilities for 2021 were $11.027B, a 16.23% decline from 2020.

Teva Pharmaceutical Industries Total Current Liabilities 2010-2024 | TEVA

  • Teva Pharmaceutical Industries total current liabilities for 2023 were $12.247B, a 6.78% increase from 2022.
  • Teva Pharmaceutical Industries total current liabilities for 2022 were $11.469B, a 4.01% increase from 2021.
  • Teva Pharmaceutical Industries total current liabilities for 2021 were $11.027B, a 16.23% decline from 2020.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$12B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Sol-Gel Technologies (SLGL)$12M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M